Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Haynes

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Brain Sciences|November 25, 2023
Calcium-Dependent Interaction of Nitric Oxide Synthase with Cytochrome <i>c</i> Oxidase: Implications for Brain BioenergeticsVirginia Haynes, Cecilia Giulivi
Drugs & Aging|April 17, 2007
Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderlyAyman M Noreddin, Virginia Haynes
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|June 24, 2005
Differential requirements of calcium for oxoglutarate dehydrogenase and mitochondrial nitric-oxide synthase under hypoxia: impact on the regulation of mitochondrial oxygen consumptionJoseph Solien, Virginia Haynes, Cecilia Giulivi
Attention Deficit and Hyperactivity Disorders|June 28, 2015
Attention-deficit/hyperactivity disorder Under Treatment Outcomes Research (AUTOR): a European observational study in pediatric subjectsVirginia Haynes, Pedro Lopez-Romero, Ernie Anand
Pragmatic and Observational Research|July 28, 2014
Diagnosis, treatment, and burden of illness among adults with attention-deficit/hyperactivity disorder in EuropeStephen L Able, Virginia Haynes, Jihyung Hong
Journal of Bioenergetics and Biomembranes|September 21, 2004
Mitochondrial nitric-oxide synthase: enzyme expression, characterization, and regulationVirginia Haynes, Sarah Elfering, Nathaniel Traaseth, et al.
Recent Patents on Anti-Infective Drug Discovery|January 29, 2008
Optimal dosing design for antibiotic therapy in the elderly: a pharmacokinetic and pharmacodynamic perspectiveAyman M Noreddin, Walid El-Khatib, Virginia Haynes
Biochimica Et Biophysica Acta|July 30, 2004
Role of calcium signaling in the activation of mitochondrial nitric oxide synthase and citric acid cycleNathaniel Traaseth, Sarah Elfering, Joseph Solien, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Adaptive Design Applied to Identification of the Minimum Effective Dose in Schizophrenia: Simulations of Scientific and Commercial ValueTom Parke, Vladimir Dragalin, Ibrahim Turkoz, et al.
Applied Health Economics and Health Policy|March 30, 2013
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparisonCarlos I Alatorre, Virginia Haynes, Douglas Faries, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Brain Sciences|November 25, 2023
Calcium-Dependent Interaction of Nitric Oxide Synthase with Cytochrome <i>c</i> Oxidase: Implications for Brain BioenergeticsVirginia Haynes, Cecilia Giulivi
Drugs & Aging|April 17, 2007
Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderlyAyman M Noreddin, Virginia Haynes
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|June 24, 2005
Differential requirements of calcium for oxoglutarate dehydrogenase and mitochondrial nitric-oxide synthase under hypoxia: impact on the regulation of mitochondrial oxygen consumptionJoseph Solien, Virginia Haynes, Cecilia Giulivi
Attention Deficit and Hyperactivity Disorders|June 28, 2015
Attention-deficit/hyperactivity disorder Under Treatment Outcomes Research (AUTOR): a European observational study in pediatric subjectsVirginia Haynes, Pedro Lopez-Romero, Ernie Anand
Pragmatic and Observational Research|July 28, 2014
Diagnosis, treatment, and burden of illness among adults with attention-deficit/hyperactivity disorder in EuropeStephen L Able, Virginia Haynes, Jihyung Hong
Journal of Bioenergetics and Biomembranes|September 21, 2004
Mitochondrial nitric-oxide synthase: enzyme expression, characterization, and regulationVirginia Haynes, Sarah Elfering, Nathaniel Traaseth, et al.
Recent Patents on Anti-Infective Drug Discovery|January 29, 2008
Optimal dosing design for antibiotic therapy in the elderly: a pharmacokinetic and pharmacodynamic perspectiveAyman M Noreddin, Walid El-Khatib, Virginia Haynes
Biochimica Et Biophysica Acta|July 30, 2004
Role of calcium signaling in the activation of mitochondrial nitric oxide synthase and citric acid cycleNathaniel Traaseth, Sarah Elfering, Joseph Solien, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Adaptive Design Applied to Identification of the Minimum Effective Dose in Schizophrenia: Simulations of Scientific and Commercial ValueTom Parke, Vladimir Dragalin, Ibrahim Turkoz, et al.
Applied Health Economics and Health Policy|March 30, 2013
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparisonCarlos I Alatorre, Virginia Haynes, Douglas Faries, et al.
Pageof 2